Lineage Cell Therapeutics, Inc.
LCTX
$1.11
$0.032.78%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 20.20% | 11.43% | 16.68% | 23.77% | 9.85% |
| Total Receivables | 273.44% | 931.46% | 144.83% | -68.64% | 8.94% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -9.34% | 81.07% | -29.86% | 26.42% | -22.71% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 25.70% | 25.70% | -- | -- | -- |
| Total Current Assets | 20.81% | 12.36% | 16.00% | 22.85% | 8.55% |
|
|
|||||
| Total Current Assets | 20.81% | 12.36% | 16.00% | 22.85% | 8.55% |
| Net Property, Plant & Equipment | 10.04% | 14.09% | 6.87% | 2.13% | -11.52% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 0.00% | -31.89% | -31.89% | -31.89% | -31.89% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1,151.86% | 1,164.48% | 935.50% | -11.06% | -14.55% |
| Total Assets | 16.98% | -1.99% | -0.56% | -7.20% | -11.68% |
|
|
|||||
| Total Accounts Payable | 2.61% | 258.80% | 99.40% | -4.94% | -37.31% |
| Total Accrued Expenses | 30.37% | 33.29% | 13.54% | 5.28% | 12.32% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -9.26% | -26.69% | -25.95% | -6.24% | -6.01% |
| Total Finance Division Other Current Liabilities | -68.08% | -75.24% | -54.89% | -54.35% | -42.50% |
| Total Other Current Liabilities | -68.08% | -75.24% | -54.89% | -54.35% | -42.50% |
| Total Current Liabilities | -25.47% | -37.75% | -18.67% | -32.33% | -29.58% |
|
|
|||||
| Total Current Liabilities | -25.47% | -37.75% | -18.67% | -32.33% | -29.58% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 21.88% | 43.70% | 14.98% | -3.60% | -39.76% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 16.44% | 136.46% | 169.83% | 254.75% | 69.14% |
| Total Liabilities | 6.26% | 66.69% | 91.23% | 116.49% | 21.60% |
|
|
|||||
| Common Stock & APIC | 9.21% | 8.24% | 6.34% | 5.31% | 4.83% |
| Retained Earnings | -7.36% | -15.75% | -15.75% | -16.91% | -10.30% |
| Treasury Stock & Other | -9.15% | -48.12% | -36.30% | -48.30% | -65.91% |
| Total Common Equity | 25.90% | -31.83% | -43.16% | -66.70% | -29.16% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 25.90% | -31.83% | -43.16% | -66.70% | -29.16% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 12.18% | 14.06% | 12.13% | 10.63% | 10.67% |
| Total Equity | 26.93% | -32.14% | -43.72% | -67.90% | -29.55% |
|
|
|||||